{"id":9379,"date":"2026-10-31T03:17:04","date_gmt":"2026-10-31T00:17:04","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/?p=9379"},"modified":"2026-10-31T03:17:04","modified_gmt":"2026-10-31T00:17:04","slug":"hepatit-b-tahlilleri","status":"publish","type":"post","link":"https:\/\/merkezlaboratuvari.com\/ar\/hepatit-b-tahlilleri\/","title":{"rendered":"Hepatit B Tahlilleri: HBsAg, Anti-HBs ve Anti-HBc Sonu\u00e7lar\u0131 Nas\u0131l Okunur"},"content":{"rendered":"<p>Hepatit B testi, \u00e7o\u011fu zaman tek bir test de\u011fil, \u00fc\u00e7 kan testinden olu\u015fan bir paneldir: HBsAg, anti-HBs ve total anti-HBc. CDC ve T\u00fcrkiye Karaci\u011fer Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (TKAD) k\u0131lavuzlar\u0131 ilk de\u011ferlendirmede bu \u00fc\u00e7\u00fcn\u00fcn birlikte istenmesini \u00f6nerir; \u00e7\u00fcnk\u00fc sonu\u00e7lar tek tek de\u011fil, birlikte okundu\u011funda aktif enfeksiyonu, ge\u00e7irilmi\u015f enfeksiyonu, a\u015f\u0131yla kazan\u0131lm\u0131\u015f ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n olmad\u0131\u011f\u0131 durumu birbirinden ay\u0131r\u0131r.<\/p>\n<p>Bu sayfa, hepatit B tahlili raporundaki \u00fc\u00e7 sat\u0131r\u0131n hangi s\u0131rayla okundu\u011funu, s\u0131k g\u00f6r\u00fclen kombinasyonlar\u0131n genel anlam\u0131n\u0131, yan\u0131ltabilen durumlar\u0131 ve panelin d\u0131\u015f\u0131nda kalan testlerin yerini anlat\u0131r. Tek bir testin ayr\u0131nt\u0131s\u0131 i\u00e7in ilgili yaz\u0131lara ba\u011flant\u0131 verilir. Bilgiler genel bilgilendirme ama\u00e7l\u0131d\u0131r; ki\u015fisel de\u011ferlendirme i\u00e7in hekime ba\u015fvurulmal\u0131d\u0131r.<\/p>\n<blockquote>\n<p><strong>\u00d6zet<\/strong><br \/>\n&#8211; Hepatit B tahlili genellikle HBsAg, anti-HBs ve total anti-HBc testlerinden olu\u015fur; \u00fc\u00e7\u00fc birlikte yorumlan\u0131r.<br \/>\n&#8211; HBsAg vir\u00fcs\u00fcn varl\u0131\u011f\u0131n\u0131, anti-HBs ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131, anti-HBc ise vir\u00fcsle kar\u015f\u0131la\u015f\u0131l\u0131p kar\u015f\u0131la\u015f\u0131lmad\u0131\u011f\u0131n\u0131 g\u00f6sterir; anti-HBc a\u015f\u0131yla olu\u015fmaz.<br \/>\n&#8211; Raporu okurken s\u0131ra HBsAg, anti-HBc, anti-HBs \u015feklinde izlenebilir.<br \/>\n&#8211; Yaln\u0131zca anti-HBc pozitifli\u011fi (izole anti-HBc) birden fazla nedene ba\u011fl\u0131 olabilir ve ek de\u011ferlendirme gerektirir.<br \/>\n&#8211; Sonu\u00e7lar tek ba\u015f\u0131na tan\u0131 koydurmaz; yorum ve karar hekime aittir.<\/p>\n<\/blockquote>\n<h2>Hepatit B Tahlili Hangi Testlerden Olu\u015fur?<\/h2>\n<p>Hepatit B vir\u00fcs\u00fc (HBV) karaci\u011feri etkileyen bir vir\u00fcst\u00fcr. Laboratuvarda vir\u00fcs\u00fcn kendisi (antijenleri ve genetik materyali) ya da ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin \u00fcretti\u011fi antikorlar aran\u0131r. Temel panelde \u00fc\u00e7 test yer al\u0131r:<\/p>\n\n<figure class=\"wp-block-table\"><table>\n<thead>\n<tr>\n<th>Test<\/th>\n<th>Neyi g\u00f6sterir<\/th>\n<th>Tek ba\u015f\u0131na neden yetmez<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"\/test-listesi\/hbsag\/\">HBsAg<\/a><\/td>\n<td>Vir\u00fcs\u00fcn y\u00fczey antijeni: vir\u00fcs\u00fcn kanda bulundu\u011funu g\u00f6sterir<\/td>\n<td>Akut ve kronik enfeksiyonu ay\u0131rt etmez; negatifli\u011fi ba\u011f\u0131\u015f\u0131kl\u0131k anlam\u0131na gelmez<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/test-listesi\/anti-hbs\/\">Anti-HBs<\/a><\/td>\n<td>Y\u00fczey antijenine kar\u015f\u0131 antikor: a\u015f\u0131 veya ge\u00e7irilmi\u015f enfeksiyon sonras\u0131 ba\u011f\u0131\u015f\u0131kl\u0131k<\/td>\n<td>Pozitifli\u011fin kayna\u011f\u0131 (a\u015f\u0131 m\u0131, ge\u00e7irilmi\u015f enfeksiyon mu) tek ba\u015f\u0131na anla\u015f\u0131lmaz<\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/test-listesi\/anti-hbc-total\/\">Total anti-HBc<\/a><\/td>\n<td>Vir\u00fcs\u00fcn kor (\u00e7ekirdek) antijenine kar\u015f\u0131 toplam antikor: vir\u00fcsle kar\u015f\u0131la\u015f\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6sterir<\/td>\n<td>Aktif mi ge\u00e7irilmi\u015f mi oldu\u011funu ay\u0131rt etmez<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/figure>\n\n<p>HBsAg&#8217;nin pozitif ve negatif sonu\u00e7lar\u0131n\u0131n ayr\u0131nt\u0131s\u0131 <a href=\"\/hbsag-nedir\/\">HBsAg nedir<\/a> yaz\u0131s\u0131nda anlat\u0131lm\u0131\u015ft\u0131r. Bu sayfa panelin b\u00fct\u00fcn\u00fcne odaklan\u0131r.<\/p>\n<h2>Hepatit B Tahlili Sonu\u00e7lar\u0131 \u00dc\u00e7 Ad\u0131mda Nas\u0131l Okunur?<\/h2>\n<p>A\u015fa\u011f\u0131daki s\u0131ra, k\u0131lavuzlardaki bir algoritma de\u011fil, bu sayfan\u0131n anlat\u0131m d\u00fczenidir; hekim de\u011ferlendirmesinin yerine ge\u00e7mez.<\/p>\n<ol>\n<li><strong>HBsAg&#8217;ye bak\u0131l\u0131r.<\/strong> Pozitifse vir\u00fcs kanda bulunmaktad\u0131r; akut ya da kronik enfeksiyon d\u00fc\u015f\u00fcn\u00fcl\u00fcr ve ek de\u011ferlendirme gerekir. CDC&#8217;ye g\u00f6re HBsAg&#8217;nin en az 6 ay s\u00fcregen pozitif kalmas\u0131 kronik enfeksiyonu tan\u0131mlar. Negatifse ikinci ad\u0131ma ge\u00e7ilir.<\/li>\n<li><strong>Total anti-HBc&#8217;ye bak\u0131l\u0131r.<\/strong> CDC&#8217;ye g\u00f6re total anti-HBc, aktif ya da iyile\u015fmi\u015f her HBV enfeksiyonunda geli\u015fir ve genellikle \u00f6m\u00fcr boyu kal\u0131r; a\u015f\u0131yla ba\u011f\u0131\u015f\u0131kl\u0131k kazanan ki\u015fide geli\u015fmez (CDC 2023). Negatifse vir\u00fcsle kar\u015f\u0131la\u015f\u0131lmad\u0131\u011f\u0131 d\u00fc\u015f\u00fcn\u00fcl\u00fcr; pozitifse ge\u00e7irilmi\u015f enfeksiyon ya da a\u015fa\u011f\u0131da anlat\u0131lan \u00f6zel durumlar akla gelir.<\/li>\n<li><strong>Anti-HBs&#8217;ye bak\u0131l\u0131r.<\/strong> Pozitifse ba\u011f\u0131\u015f\u0131kl\u0131k vard\u0131r; anti-HBc&#8217;nin de pozitif olup olmamas\u0131na g\u00f6re bu ba\u011f\u0131\u015f\u0131kl\u0131k ge\u00e7irilmi\u015f enfeksiyona ya da a\u015f\u0131ya dayan\u0131r. Negatifse koruyucu d\u00fczeyde antikor saptanmam\u0131\u015ft\u0131r.<\/li>\n<\/ol>\n<h2>Sonu\u00e7 Kombinasyonlar\u0131 ve Genel Anlamlar\u0131<\/h2>\n<p>Tablo, CDC&#8217;nin 2023 tarihli tarama \u00f6nerilerindeki yorum \u00e7er\u00e7evesine (CDC 2023, Tablo 1) dayan\u0131r. Her sat\u0131r\u0131n sonundaki &#8220;ayr\u0131nt\u0131&#8221; s\u00fctunu, konunun hangi sayfada daha geni\u015f anlat\u0131ld\u0131\u011f\u0131n\u0131 g\u00f6sterir.<\/p>\n\n<figure class=\"wp-block-table\"><table>\n<thead>\n<tr>\n<th>Profil<\/th>\n<th>HBsAg<\/th>\n<th>Total anti-HBc<\/th>\n<th>Anti-HBs<\/th>\n<th>Genel anlam<\/th>\n<th>Ayr\u0131nt\u0131<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Hi\u00e7 kar\u015f\u0131la\u015f\u0131lmam\u0131\u015f, ba\u011f\u0131\u015f\u0131kl\u0131k yok<\/td>\n<td>Negatif<\/td>\n<td>Negatif<\/td>\n<td>Negatif<\/td>\n<td>Vir\u00fcsle kar\u015f\u0131la\u015f\u0131lmam\u0131\u015f; ba\u011f\u0131\u015f\u0131kl\u0131k yok<\/td>\n<td><a href=\"\/anti-hbs-nedir\/\">Anti-HBs yaz\u0131s\u0131<\/a><\/td>\n<\/tr>\n<tr>\n<td>A\u015f\u0131yla ba\u011f\u0131\u015f\u0131kl\u0131k<\/td>\n<td>Negatif<\/td>\n<td>Negatif<\/td>\n<td>Pozitif<\/td>\n<td>A\u015f\u0131ya ba\u011fl\u0131 ba\u011f\u0131\u015f\u0131kl\u0131k<\/td>\n<td><a href=\"\/anti-hbs-nedir\/\">Anti-HBs yaz\u0131s\u0131<\/a><\/td>\n<\/tr>\n<tr>\n<td>Ge\u00e7irilmi\u015f, iyile\u015fmi\u015f enfeksiyon<\/td>\n<td>Negatif<\/td>\n<td>Pozitif<\/td>\n<td>Pozitif<\/td>\n<td>Ge\u00e7irilmi\u015f enfeksiyon sonras\u0131 ba\u011f\u0131\u015f\u0131kl\u0131k<\/td>\n<td><a href=\"\/anti-hbc-nedir\/\">Anti-HBc yaz\u0131s\u0131<\/a><\/td>\n<\/tr>\n<tr>\n<td>Akut enfeksiyon<\/td>\n<td>Pozitif<\/td>\n<td>Pozitif (IgM anti-HBc pozitif)<\/td>\n<td>Negatif<\/td>\n<td>Yak\u0131n zamanda al\u0131nm\u0131\u015f enfeksiyonla uyumlu<\/td>\n<td><a href=\"\/hbsag-nedir\/\">HBsAg nedir<\/a><\/td>\n<\/tr>\n<tr>\n<td>Kronik enfeksiyon<\/td>\n<td>Pozitif<\/td>\n<td>Pozitif (IgM anti-HBc negatif)<\/td>\n<td>Negatif<\/td>\n<td>S\u00fcregen enfeksiyonla uyumlu<\/td>\n<td><a href=\"\/hbsag-nedir\/\">HBsAg nedir<\/a>; <a href=\"\/hbv-dna-nedir\/\">HBV DNA yaz\u0131s\u0131<\/a><\/td>\n<\/tr>\n<tr>\n<td>\u0130zole anti-HBc<\/td>\n<td>Negatif<\/td>\n<td>Pozitif<\/td>\n<td>Negatif<\/td>\n<td>Tek bir anlam\u0131 yok; nedene ba\u011fl\u0131<\/td>\n<td><a href=\"\/anti-hbc-nedir\/\">Anti-HBc yaz\u0131s\u0131<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/figure>\n\n<p>Tablo genel bir \u00e7er\u00e7evedir. Kronik enfeksiyonda IgM anti-HBc alevlenme d\u00f6nemlerinde pozitifle\u015febilir; bu nedenle akut ve kronik ayr\u0131m\u0131 yaln\u0131zca bir teste dayand\u0131r\u0131lmaz (CDC 2023, TKAD 2023).<\/p>\n<h3>Okurken Yan\u0131ltabilen Durumlar<\/h3>\n<ul>\n<li><strong>\u0130zole anti-HBc:<\/strong> CDC, bu profilin nedenleri aras\u0131nda ge\u00e7irilmi\u015f enfeksiyondan sonra anti-HBs d\u00fczeyinin azalmas\u0131n\u0131, gizli (ok\u00fclt) enfeksiyonu, anti-HBs olu\u015fmadan \u00f6nceki k\u0131sa d\u00f6nemi, yanl\u0131\u015f pozitifli\u011fi ve testte saptanamayan vir\u00fcs varyantlar\u0131n\u0131 sayar. Bebeklerde anneden pasif ge\u00e7en antikor nedeniyle de pozitif olabilir (CDC 2023). Nedenin ayr\u0131m\u0131 ek testlerle ve hekim de\u011ferlendirmesiyle yap\u0131l\u0131r.<\/li>\n<li><strong>A\u015f\u0131 sonras\u0131 ge\u00e7ici HBsAg:<\/strong> CDC, a\u015f\u0131dan hemen sonra HBsAg&#8217;nin k\u0131sa s\u00fcreli ve ge\u00e7ici olarak pozitif \u00e7\u0131kabildi\u011fini belirtir. A\u015f\u0131 olma tarihi hekimle ve laboratuvarla payla\u015f\u0131lmal\u0131d\u0131r.<\/li>\n<li><strong>Ba\u011f\u0131\u015f\u0131kl\u0131k globulini sonras\u0131 anti-HBs:<\/strong> Hepatit B ba\u011f\u0131\u015f\u0131kl\u0131k globulini (HBIG) uygulanan ki\u015filerde pasif olarak ge\u00e7en anti-HBs 4\u20136 ay kadar \u00f6l\u00e7\u00fclebilir; bu d\u00f6nemde bak\u0131lan anti-HBs ki\u015finin kendi ba\u011f\u0131\u015f\u0131kl\u0131k durumunu yans\u0131tmayabilir (CDC 2023).<\/li>\n<li><strong>Yak\u0131n zamanl\u0131 temas:<\/strong> Enfeksiyonun \u00e7ok erken d\u00f6neminde HBsAg hen\u00fcz saptanabilir d\u00fczeye ula\u015fmam\u0131\u015f olabilir; bu nedenle erken yap\u0131lan test negatif \u00e7\u0131kabilir. Test zamanlamas\u0131 hekim taraf\u0131ndan belirlenir.<\/li>\n<\/ul>\n<h2>Sonu\u00e7 Zamanla Nas\u0131l De\u011fi\u015fir?<\/h2>\n<p>Hepatit B serolojisi sabit bir foto\u011fraf de\u011fil, zaman i\u00e7inde de\u011fi\u015fen bir tablodur. Akut enfeksiyonda HBsAg kanda belirir; enfeksiyon iyile\u015firse HBsAg kaybolur ve ard\u0131ndan anti-HBs geli\u015fir. CDC, HBsAg azald\u0131ktan sonra anti-HBs&#8217;nin ortaya \u00e7\u0131kmas\u0131n\u0131 iyile\u015fmenin g\u00f6stergesi olarak tan\u0131mlar. Total anti-HBc ise iyile\u015fmeden sonra da genellikle \u00f6m\u00fcr boyu pozitif kal\u0131r. Anti-HBs d\u00fczeyi zamanla azalabilir; CDC&#8217;nin ACIP raporu, a\u015f\u0131ya yan\u0131t vermi\u015f ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 normal ki\u015filerde d\u00fczeyin sonradan azalmas\u0131n\u0131n tek ba\u015f\u0131na koruyuculu\u011fun kayb\u0131 anlam\u0131na gelmedi\u011fini belirtir (CDC 2018).<\/p>\n<p>Bu nedenle farkl\u0131 tarihlerdeki sonu\u00e7lar ayn\u0131 laboratuvar\u0131n raporlar\u0131nda bile farkl\u0131 g\u00f6r\u00fcnebilir. \u00d6nceki raporlar\u0131n hekimle payla\u015f\u0131lmas\u0131 yorumu kolayla\u015ft\u0131r\u0131r.<\/p>\n<h2>Panelin D\u0131\u015f\u0131ndaki Testler: IgM Anti-HBc, HBeAg\/Anti-HBe ve HBV DNA<\/h2>\n<p>HBsAg pozitif ya da anti-HBc pozitif bulundu\u011funda hekim ek test isteyebilir (TKAD 2023, CDC 2023). Bunlar panelin par\u00e7as\u0131 de\u011fil, ikinci basamak testlerdir:<\/p>\n<ul>\n<li><strong><a href=\"\/test-listesi\/anti-hbc-igm\/\">IgM anti-HBc<\/a>:<\/strong> CDC&#8217;ye g\u00f6re yaln\u0131zca akut enfeksiyondan \u015f\u00fcphelenildi\u011finde istenmelidir; akut ve kronik tablonun ayr\u0131m\u0131na yard\u0131mc\u0131 olur.<\/li>\n<li><strong><a href=\"\/test-listesi\/hbeag\/\">HBeAg<\/a> ve <a href=\"\/test-listesi\/anti-hbe\/\">anti-HBe<\/a>:<\/strong> Vir\u00fcs\u00fcn \u00e7o\u011falma durumunu de\u011ferlendirmeye yard\u0131mc\u0131 g\u00f6stergelerdir.<\/li>\n<li><strong><a href=\"\/test-listesi\/hbv-dna-kantitatif\/\">HBV DNA<\/a>:<\/strong> Kandaki vir\u00fcs miktar\u0131n\u0131 (viral y\u00fck) \u00f6l\u00e7er. TKAD k\u0131lavuzuna g\u00f6re HBV DNA d\u00fczeyi dalgalanabilir; tek \u00f6l\u00e7\u00fcmle tan\u0131 konmaz. Ayr\u0131nt\u0131s\u0131 HBV DNA yaz\u0131s\u0131nda ele al\u0131nmaktad\u0131r. Bkz. <a href=\"\/hbv-dna-nedir\/\">HBV DNA yaz\u0131s\u0131<\/a>.<\/li>\n<li><strong>Karaci\u011fer testleri (ALT, AST):<\/strong> Karaci\u011ferin etkilenme d\u00fczeyini de\u011ferlendirmek i\u00e7in bak\u0131l\u0131r.<\/li>\n<\/ul>\n<p>Hangi testlerin istenece\u011fine hekim karar verir.<\/p>\n<h2>Anti-HBs Say\u0131s\u0131 Nas\u0131l Okunur?<\/h2>\n<p>Anti-HBs sonucu, laboratuvar\u0131n y\u00f6ntemine g\u00f6re say\u0131sal (kantitatif) ya da pozitif\/negatif olarak raporlanabilir. A\u015f\u0131 serisini tamamlayan ki\u015filerde ba\u011f\u0131\u015f\u0131kl\u0131k g\u00f6stergesi olarak kullan\u0131lan genel k\u0131lavuz de\u011feri, serinin bitiminden 1\u20132 ay sonra anti-HBs&#8217;nin 10 mIU\/mL ve \u00fczerinde olmas\u0131d\u0131r (CDC 2018). Birim, y\u00f6ntem ve e\u015fik laboratuvara g\u00f6re de\u011fi\u015febilir; rapordaki laboratuvar aral\u0131\u011f\u0131 esast\u0131r. <a href=\"\/test-listesi\/anti-hbs\/\">Anti-HBs test sayfas\u0131nda<\/a> da 10 mIU\/mL ve \u00fczeri de\u011ferlerin ba\u011f\u0131\u015f\u0131kl\u0131k lehine de\u011ferlendirildi\u011fi belirtilir; sonu\u00e7 raporda yazan laboratuvar aral\u0131\u011f\u0131yla ve hekim taraf\u0131ndan de\u011ferlendirilir. De\u011ferlerin ayr\u0131nt\u0131s\u0131 Anti-HBs yaz\u0131s\u0131nda ele al\u0131n\u0131r. Bkz. <a href=\"\/anti-hbs-nedir\/\">Anti-HBs yaz\u0131s\u0131<\/a>.<\/p>\n<h2>Hepatit B Tahlili Kimlerde \u0130stenir?<\/h2>\n<p>TKAD 2023 k\u0131lavuzu, T\u00fcrkiye&#8217;de HBsAg pozitiflik oran\u0131n\u0131n %3&#8217;\u00fcn \u00fczerinde oldu\u011funu belirterek her eri\u015fkinin ya\u015fam\u0131nda en az bir kez taranmas\u0131n\u0131 uygun bulur. K\u0131lavuz ayr\u0131ca baz\u0131 gruplar\u0131n \u00f6ncelikli taranmas\u0131n\u0131 \u00f6nerir; \u00f6rne\u011fin:<\/p>\n<ul>\n<li>HBsAg pozitif gebeden do\u011fan bebekler ve HBsAg pozitif ki\u015fiyle ayn\u0131 evde ya\u015fayanlar,<\/li>\n<li>gebeler (rutin tarama) ve sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131,<\/li>\n<li>a\u00e7\u0131klanamayan ALT ya da AST y\u00fcksekli\u011fi olanlar,<\/li>\n<li>hemodiyaliz hastalar\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131layan tedavi (kemoterapi, biyolojik ajanlar gibi) g\u00f6recek ki\u015filer,<\/li>\n<li>kan, organ ve doku vericileri ya da al\u0131c\u0131lar\u0131,<\/li>\n<li>HIV ya da hepatit C ile ya\u015fayanlar ve HBV testi talep eden ki\u015filer.<\/li>\n<\/ul>\n<p>\u0130stem karar\u0131 ve zamanlamas\u0131 hekime aittir.<\/p>\n<h2>Numune ve Sonu\u00e7 S\u00fcresi<\/h2>\n<p>Panelin testleri ven\u00f6z kandan al\u0131nan serum numunesiyle \u00e7al\u0131\u015f\u0131l\u0131r; HBV DNA kantitatif testi plazma numunesi kullan\u0131r. Her testin numune t\u00fcr\u00fc, a\u00e7l\u0131k gereksinimi ve raporlama zaman\u0131 kendi test sayfas\u0131nda belirtilir: <a href=\"\/test-listesi\/hbsag\/\">HBsAg<\/a>, <a href=\"\/test-listesi\/anti-hbs\/\">anti-HBs<\/a>, <a href=\"\/test-listesi\/anti-hbc-total\/\">total anti-HBc<\/a> ve <a href=\"\/test-listesi\/hbv-dna-kantitatif\/\">HBV DNA<\/a>. Genel bilgi i\u00e7in <a href=\"\/kan-tahlili-sonucu-ne-zaman-cikar\/\">kan tahlili sonucu ne zaman \u00e7\u0131kar<\/a> sayfas\u0131na bak\u0131labilir. T\u00fcrkiye&#8217;de hepatit B, bildirimi zorunlu bula\u015f\u0131c\u0131 hastal\u0131klar aras\u0131ndad\u0131r; bildirim y\u00fck\u00fcml\u00fcl\u00fc\u011f\u00fc Bula\u015f\u0131c\u0131 Hastal\u0131klar S\u00fcrveyans ve Kontrol Esaslar\u0131 Y\u00f6netmeli\u011fi uyar\u0131nca sa\u011fl\u0131k hizmeti sunan kurumlara aittir.<\/p>\n<h2>Di\u011fer Hepatit Testleri<\/h2>\n<p>Hepatit B, birden \u00e7ok hepatit vir\u00fcs\u00fcnden yaln\u0131zca biridir. Hepatit C i\u00e7in <a href=\"\/anti-hcv-nedir\/\">anti-HCV nedir<\/a> yaz\u0131s\u0131na bak\u0131labilir. Hepatit A ayr\u0131 bir vir\u00fcst\u00fcr, kronik h\u00e2le gelmez (WHO Hepatit A bilgi notu) ve kendi antikor testi vard\u0131r: <a href=\"\/test-listesi\/anti-hav-total\/\">anti-HAV total<\/a>.<\/p>\n<h2>Ne Zaman Hekime Ba\u015fvurulmal\u0131?<\/h2>\n<p>Hepatit B tahlili sonucu, ki\u015finin \u00f6yk\u00fcs\u00fc, a\u015f\u0131 durumu, belirtileri ve di\u011fer bulgular\u0131yla birlikte hekim taraf\u0131ndan yorumlan\u0131r. HBsAg ya da anti-HBc pozitif, ya da sonu\u00e7lar birbiriyle uyumsuz g\u00f6r\u00fcn\u00fcyorsa de\u011ferlendirme i\u00e7in hekime ba\u015fvurulmal\u0131d\u0131r. Sar\u0131l\u0131k, a\u00e7\u0131klanamayan s\u00fcrekli halsizlik, koyu renkli idrar ya da kar\u0131n \u00fcst b\u00f6lgesinde a\u011fr\u0131 gibi \u015fik\u00e2yetler varsa, gebelik varsa veya ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131layan bir tedavi planlan\u0131yorsa da hekim de\u011ferlendirmesi gerekir. Sonu\u00e7, kendi ba\u015f\u0131na yorumlan\u0131p ila\u00e7 ya da a\u015f\u0131 karar\u0131 i\u00e7in tek dayanak yap\u0131lmamal\u0131d\u0131r.<\/p>\n<h2>S\u0131k\u00e7a Sorulan Sorular<\/h2>\n<h3>Hepatit B tahlili hangi testlerden olu\u015fur?<\/h3>\n<p>Hepatit B tahlili (hepatit B testi), genellikle \u00fc\u00e7 kan testinden olu\u015fan bir paneli ifade eder: HBsAg (vir\u00fcs\u00fcn y\u00fczey antijeni), anti-HBs (y\u00fczey antijenine kar\u015f\u0131 antikor) ve total anti-HBc (kor antijenine kar\u015f\u0131 toplam antikor). CDC ve TKAD k\u0131lavuzlar\u0131 ilk de\u011ferlendirmede bu \u00fc\u00e7 testin birlikte istenmesini \u00f6nerir. Sonu\u00e7 hekim taraf\u0131ndan de\u011ferlendirilir.<\/p>\n<h3>HBsAg negatif, anti-HBs pozitif ne demek?<\/h3>\n<p>Anti-HBc de negatifse bu profil genel olarak a\u015f\u0131yla kazan\u0131lm\u0131\u015f ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 g\u00f6sterir. Anti-HBc pozitifse ge\u00e7irilmi\u015f ve iyile\u015fmi\u015f enfeksiyon d\u00fc\u015f\u00fcn\u00fcl\u00fcr. \u00dc\u00e7 sonucun birlikte de\u011ferlendirilmesi gerekir; yorum hekime aittir.<\/p>\n<h3>Yaln\u0131zca anti-HBc pozitif \u00e7\u0131karsa ne anlama gelir?<\/h3>\n<p>HBsAg ve anti-HBs negatifken yaln\u0131zca anti-HBc pozitif olmas\u0131 izole anti-HBc olarak adland\u0131r\u0131l\u0131r. Ge\u00e7irilmi\u015f enfeksiyon sonras\u0131 anti-HBs&#8217;nin azalmas\u0131, gizli enfeksiyon, yanl\u0131\u015f pozitiflik gibi farkl\u0131 nedenleri olabilir. Nedeni ek de\u011ferlendirmeyle hekim belirler.<\/p>\n<h3>Hepatit B a\u015f\u0131s\u0131 olan ki\u015fide testte ne g\u00f6r\u00fcn\u00fcr?<\/h3>\n<p>A\u015f\u0131yla ba\u011f\u0131\u015f\u0131kl\u0131k kazanan ki\u015fide genellikle yaln\u0131zca anti-HBs pozitif bulunur; HBsAg ve anti-HBc negatiftir, \u00e7\u00fcnk\u00fc anti-HBc a\u015f\u0131yla olu\u015fmaz. A\u015f\u0131 sonras\u0131 k\u0131lavuz de\u011feri, a\u015f\u0131 serisinin tamamlanmas\u0131ndan 1\u20132 ay sonra anti-HBs&#8217;nin 10 mIU\/mL ve \u00fczerinde olmas\u0131d\u0131r (CDC 2018); laboratuvar raporundaki aral\u0131k esast\u0131r.<\/p>\n<h3>Hepatit B pozitif \u00e7\u0131karsa ne olur?<\/h3>\n<p>HBsAg pozitifli\u011fi hepatit B vir\u00fcs\u00fcn\u00fcn bulundu\u011funu g\u00f6sterir; ayr\u0131nt\u0131 HBsAg nedir yaz\u0131s\u0131nda anlat\u0131lm\u0131\u015ft\u0131r ve sonraki ad\u0131mlara hekim karar verir.<\/p>\n<h3>Hepatit B testi kimlere istenir?<\/h3>\n<p>TKAD k\u0131lavuzu, T\u00fcrkiye&#8217;de HBsAg pozitiflik oran\u0131n\u0131n %3&#8217;\u00fcn \u00fczerinde olmas\u0131 nedeniyle her eri\u015fkinin ya\u015fam\u0131nda en az bir kez taranmas\u0131n\u0131 uygun bulur; gebeler, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131, ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131layan tedavi g\u00f6recek ki\u015filer ve HBsAg pozitif ki\u015finin yak\u0131nlar\u0131 gibi gruplarda tarama \u00f6nceliklidir. \u0130stem karar\u0131 hekime aittir.<\/p>\n<h2>\u0130lgili Testler ve Yaz\u0131lar<\/h2>\n<ul>\n<li><a href=\"\/hbsag-nedir\/\">HBsAg nedir? Pozitif ve negatif ne anlama gelir<\/a><\/li>\n<li><a href=\"\/anti-hcv-nedir\/\">Anti-HCV nedir (hepatit C testi)<\/a><\/li>\n<li><a href=\"\/test-listesi\/hbsag\/\">HBsAg test sayfas\u0131<\/a><\/li>\n<li><a href=\"\/test-listesi\/anti-hbs\/\">Anti-HBs test sayfas\u0131<\/a><\/li>\n<li><a href=\"\/test-listesi\/anti-hbc-total\/\">Anti-HBc total test sayfas\u0131<\/a><\/li>\n<li><a href=\"\/test-listesi\/hbv-dna-kantitatif\/\">HBV DNA kantitatif test sayfas\u0131<\/a><\/li>\n<li><a href=\"\/test-listesi\/anti-hav-total\/\">Anti-HAV total test sayfas\u0131<\/a><\/li>\n<li><a href=\"\/hizmetler\/cinsel-yolla-bulasan-hastalik-testleri\/\">Cinsel yolla bula\u015fan hastal\u0131k testleri<\/a><\/li>\n<li><a href=\"\/anti-hbs-nedir\/\">Anti-HBs Nedir?<\/a><\/li>\n<li><a href=\"\/anti-hbc-nedir\/\">Anti-HBc Nedir?<\/a><\/li>\n<li><a href=\"\/hbv-dna-nedir\/\">HBV DNA Nedir?<\/a><\/li>\n<li><a href=\"\/anti-hav-nedir\/\">Anti-HAV Nedir?<\/a><\/li>\n<\/ul>\n<blockquote>\n<p><strong>Merkez T\u0131bbi Tahlil Laboratuvar\u0131<\/strong><br \/>\nKayaba\u015f\u0131, Kaya\u015fehir Blv. Sitesi No:40, 34220 Ba\u015fak\u015fehir\/\u0130stanbul<br \/>\nTelefon: 0212 610 01 30 (WhatsApp hatt\u0131 mevcuttur)<br \/>\n\u00c7al\u0131\u015fma saatleri: Pazartesi\u2013Cumartesi 08:30\u201318:00, Pazar kapal\u0131<br \/>\nRandevu uygulamas\u0131 bulunmamaktad\u0131r; hasta kabul\u00fc \u00e7al\u0131\u015fma saatleri i\u00e7inde yap\u0131lmaktad\u0131r.<br \/>\nArap\u00e7a bilgilendirme hizmeti mevcuttur. Sonu\u00e7lar online olarak sorgulanabilmektedir.<br \/>\n\u0130leti\u015fim: <a href=\"\/iletisim\/\">ileti\u015fim sayfas\u0131<\/a><\/p>\n<p><strong>Uyar\u0131:<\/strong> Bu sayfa yaln\u0131zca genel bilgilendirme ama\u00e7l\u0131d\u0131r; tan\u0131, tedavi veya t\u0131bbi karar yerine ge\u00e7mez. Test sonu\u00e7lar\u0131 hekim taraf\u0131ndan de\u011ferlendirilmelidir.<\/p>\n<\/blockquote>\n<p><strong>Kaynaklar<\/strong>:<br \/>\n&#8211; <a href=\"https:\/\/www.tkad.org.tr\/wp-content\/uploads\/2023\/11\/TURKIYE-HEPATIT-B-TANI-VE-TEDAVI-KLAVUZU-2023.pdf\" rel=\"nofollow noopener\" target=\"_blank\">T\u00fcrk Karaci\u011fer Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (TKAD), T\u00fcrkiye Hepatit B Tan\u0131 ve Tedavi K\u0131lavuzu, 2023<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/72\/rr\/rr7201a1.htm\" rel=\"nofollow noopener\" target=\"_blank\">Conners EE ve ark., Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations, United States, 2023, MMWR Recomm Rep 2023;72(RR-1)<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.cdc.gov\/mmwr\/volumes\/67\/rr\/rr6701a1.htm\" rel=\"nofollow noopener\" target=\"_blank\">Schillie S ve ark., Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the ACIP, MMWR Recomm Rep 2018;67(1)<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b\" rel=\"nofollow noopener\" target=\"_blank\">D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO), Hepatitis B fact sheet<\/a><br \/>\n&#8211; <a href=\"https:\/\/hsgm.saglik.gov.tr\/depo\/Yayinlarimiz\/Programlar\/Turkiye_Viral_Hepatit_Onleme_ve_Kontrol_Programi_2018-2023.pdf\" rel=\"nofollow noopener\" target=\"_blank\">T. C. Sa\u011fl\u0131k Bakanl\u0131\u011f\u0131 Halk Sa\u011fl\u0131\u011f\u0131 Genel M\u00fcd\u00fcrl\u00fc\u011f\u00fc, T\u00fcrkiye Viral Hepatit \u00d6nleme ve Kontrol Program\u0131 2018\u20132023<\/a><br \/>\n&#8211; <a href=\"https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-a\" rel=\"nofollow noopener\" target=\"_blank\">D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (WHO), Hepatitis A fact sheet<\/a><\/p>\n<p><strong>Son g\u00fcncelleme<\/strong>: 30 Ekim 2026<\/p>\n\n<script type=\"application\/ld+json\">\n{\n \"@context\": \"https:\/\/schema.org\",\n \"@graph\": [\n {\n \"@type\": \"MedicalWebPage\",\n \"name\": \"Hepatit B Tahlilleri: HBsAg, Anti-HBs ve Anti-HBc Sonu\u00e7lar\u0131 Nas\u0131l Okunur\",\n \"url\": \"https:\/\/merkezlaboratuvari.com\/hepatit-b-tahlilleri\/\",\n \"inLanguage\": \"tr\",\n \"about\": { \"@type\": \"MedicalTest\", \"name\": \"Hepatit B serolojisi (HBsAg, anti-HBs, anti-HBc)\" },\n \"dateModified\": \"2026-10-30\",\n \"publisher\": { \"@type\": \"Organization\", \"name\": \"Merkez T\u0131bbi Tahlil Laboratuvar\u0131\" }\n },\n {\n \"@type\": \"FAQPage\",\n \"mainEntity\": [\n {\"@type\": \"Question\", \"name\": \"Hepatit B tahlili hangi testlerden olu\u015fur?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Hepatit B tahlili (hepatit B testi), genellikle \u00fc\u00e7 kan testinden olu\u015fan bir paneli ifade eder: HBsAg (vir\u00fcs\u00fcn y\u00fczey antijeni), anti-HBs (y\u00fczey antijenine kar\u015f\u0131 antikor) ve total anti-HBc (kor antijenine kar\u015f\u0131 toplam antikor). CDC ve TKAD k\u0131lavuzlar\u0131 ilk de\u011ferlendirmede bu \u00fc\u00e7 testin birlikte istenmesini \u00f6nerir. Sonu\u00e7 hekim taraf\u0131ndan de\u011ferlendirilir.\"}},\n {\"@type\": \"Question\", \"name\": \"HBsAg negatif, anti-HBs pozitif ne demek?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Anti-HBc de negatifse bu profil genel olarak a\u015f\u0131yla kazan\u0131lm\u0131\u015f ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 g\u00f6sterir. Anti-HBc pozitifse ge\u00e7irilmi\u015f ve iyile\u015fmi\u015f enfeksiyon d\u00fc\u015f\u00fcn\u00fcl\u00fcr. \u00dc\u00e7 sonucun birlikte de\u011ferlendirilmesi gerekir; yorum hekime aittir.\"}},\n {\"@type\": \"Question\", \"name\": \"Yaln\u0131zca anti-HBc pozitif \u00e7\u0131karsa ne anlama gelir?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"HBsAg ve anti-HBs negatifken yaln\u0131zca anti-HBc pozitif olmas\u0131 izole anti-HBc olarak adland\u0131r\u0131l\u0131r. Ge\u00e7irilmi\u015f enfeksiyon sonras\u0131 anti-HBs'nin azalmas\u0131, gizli enfeksiyon, yanl\u0131\u015f pozitiflik gibi farkl\u0131 nedenleri olabilir. Nedeni ek de\u011ferlendirmeyle hekim belirler.\"}},\n {\"@type\": \"Question\", \"name\": \"Hepatit B a\u015f\u0131s\u0131 olan ki\u015fide testte ne g\u00f6r\u00fcn\u00fcr?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"A\u015f\u0131yla ba\u011f\u0131\u015f\u0131kl\u0131k kazanan ki\u015fide genellikle yaln\u0131zca anti-HBs pozitif bulunur; HBsAg ve anti-HBc negatiftir, \u00e7\u00fcnk\u00fc anti-HBc a\u015f\u0131yla olu\u015fmaz. A\u015f\u0131 sonras\u0131 k\u0131lavuz de\u011feri, a\u015f\u0131 serisinin tamamlanmas\u0131ndan 1\u20132 ay sonra anti-HBs'nin 10 mIU\/mL ve \u00fczerinde olmas\u0131d\u0131r (CDC 2018); laboratuvar raporundaki aral\u0131k esast\u0131r.\"}},\n {\"@type\": \"Question\", \"name\": \"Hepatit B pozitif \u00e7\u0131karsa ne olur?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"HBsAg pozitifli\u011fi hepatit B vir\u00fcs\u00fcn\u00fcn bulundu\u011funu g\u00f6sterir; ayr\u0131nt\u0131 HBsAg nedir yaz\u0131s\u0131nda anlat\u0131lm\u0131\u015ft\u0131r ve sonraki ad\u0131mlara hekim karar verir.\"}},\n {\"@type\": \"Question\", \"name\": \"Hepatit B testi kimlere istenir?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"TKAD k\u0131lavuzu, T\u00fcrkiye'de HBsAg pozitiflik oran\u0131n\u0131n %3'\u00fcn \u00fczerinde olmas\u0131 nedeniyle her eri\u015fkinin ya\u015fam\u0131nda en az bir kez taranmas\u0131n\u0131 uygun bulur; gebeler, sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131, ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 bask\u0131layan tedavi g\u00f6recek ki\u015filer ve HBsAg pozitif ki\u015finin yak\u0131nlar\u0131 gibi gruplarda tarama \u00f6nceliklidir. \u0130stem karar\u0131 hekime aittir.\"}}\n ]\n },\n {\n \"@type\": \"BreadcrumbList\",\n \"itemListElement\": [\n {\"@type\": \"ListItem\", \"position\": 1, \"name\": \"Ana Sayfa\", \"item\": \"https:\/\/merkezlaboratuvari.com\/\"},\n {\"@type\": \"ListItem\", \"position\": 2, \"name\": \"Hepatit B Tahlilleri\", \"item\": \"https:\/\/merkezlaboratuvari.com\/hepatit-b-tahlilleri\/\"}\n ]\n }\n ]\n}\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>Hepatit B testi, \u00e7o\u011fu zaman tek bir test de\u011fil, \u00fc\u00e7 kan testinden olu\u015fan bir paneldir: HBsAg, anti-HBs ve total anti-HBc. CDC ve T\u00fcrkiye Karaci\u011fer Ara\u015ft\u0131rmalar\u0131 Derne\u011fi (TKAD) k\u0131lavuzlar\u0131 ilk de\u011ferlendirmede bu \u00fc\u00e7\u00fcn\u00fcn birlikte istenmesini \u00f6nerir; \u00e7\u00fcnk\u00fc sonu\u00e7lar tek tek de\u011fil, birlikte okundu\u011funda aktif enfeksiyonu, ge\u00e7irilmi\u015f enfeksiyonu, a\u015f\u0131yla kazan\u0131lm\u0131\u015f ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131 ve ba\u011f\u0131\u015f\u0131kl\u0131\u011f\u0131n olmad\u0131\u011f\u0131 durumu birbirinden ay\u0131r\u0131r. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-9379","post","type-post","status-publish","format-standard","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/posts\/9379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=9379"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/posts\/9379\/revisions"}],"predecessor-version":[{"id":9471,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/posts\/9379\/revisions\/9471"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=9379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/categories?post=9379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/tags?post=9379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}